Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan —2012 Version
Tamio Teramoto,Jun Sasaki,Shun Ishibashi,Sadatoshi Birou,Hiroyuki Daida,Seitaro Dohi,Genshi Egusa,Takafumi Hiro,Kazuhiko Hirobe,Mami Iida,Shinji Kihara,Makoto Kinoshita,Chizuko Maruyama,Takao Ohta,Tomonori Okamura,Shizuya Yamashita,Masayuki Yokode,Koutaro Yokote +17 more
About:
This article is published in Journal of Atherosclerosis and Thrombosis.The article was published on 2013-01-01 and is currently open access. It has received 437 citations till now.read more
Citations
More filters
Journal ArticleDOI
Overlooking of Individuals with Cardiometabolic Risk by Evaluation of Obesity Using Waist Circumference and Body Mass Index in Middle-Aged Japanese Women
TL;DR: In this article , the relationship between waist-to-height ratio and cardiometabolic risk factors, including diabetes, hypertension and dyslipidemia, were investigated in middle-aged Japanese women who were diagnosed as not having obesity according to the above Japanese criteria of obesity.
Journal ArticleDOI
Combination pharmacotherapy in lipid management
TL;DR: In this article, the LDL-C (low-density lipoproteincholesterol, LDL)-C) level is defined as 1 mmol/L(approximately 39 mg/dL).
Journal ArticleDOI
Hematometabolic Index as a New Discriminator of Cardiometabolic Risk in Middle-Aged Men with Polycythemia and High Leukocyte Count in Peripheral Blood
TL;DR: In this article , a new index, named hematometabolic index (HMI), was defined as the product of hemoglobin concentration (g/dL)-minus-13.0 and leukocyte count (/μL)-plus-3000.
Book ChapterDOI
Drugs for Treatment of Dyslipidemia Available in the USA
Elani Streja,Dan Streja +1 more
TL;DR: This chapter will focus on the pharmacologic interventions for treatment of dyslipidemia in patients with chronic kidney disease (CKD).
Patent
Methods for treatment of hypertension with an angiotensin ii receptor blocker pharmaceutical composition
TL;DR: In this paper, a method for lowering blood pressure in a subject in need thereof by administering an angiotensin II receptor blocker pharmaceutical composition to a subject qualified for over-the-counter access to the drug composition is provided.
References
More filters
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National
William C. Taylor,Nigel Unwin +1 more
Journal ArticleDOI
Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
Daniel H. O'Leary,Joseph F. Polak,Richard A. Kronmal,Teri A. Manolio,Gregory L. Burke,Sidney K. Wolfson +5 more
TL;DR: Increases in the thickness of the intima and media of the carotid artery, as measured noninvasively by ultrasonography, are directly associated with an increased risk of myocardial infarction and stroke in older adults without a history of cardiovascular disease.
Journal ArticleDOI
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)☆☆☆
Alberico L. Catapano,Zeljko Reiner,Guy De Backer,Ian D. Graham,Marja-Riitta Taskinen,Olov Wiklund,Stefan Agewall,Eduardo Alegria,M. John Chapman,Paul N. Durrington,Serap Erdine,Julian Halcox,Richard J. Hobbs,John Kjekshus,Pasquale Perrone Filardi,Gabriele Riccardi,Robert F. Storey,David R. Wood +17 more
TL;DR: These Joint ESC/European Atherosclerosis Society (EAS) guidelines on the management of dyslipidaemias are complementary to the guidelines on CVD prevention in clinical practice and address not only physicians but also specialists from lipid clinics or metabolic units who are dealing with dyslipIDAemias that are more difficult to classify and treat.
Journal ArticleDOI
ESC/EAS Guidelines for the management of dyslipidaemias
Alberico L. Catapano,Željko Reiner,Guy De Backer,Ian D. Graham,Marja-Riitta Taskinen,Olov Wiklund,Stefan Agewall,Eduardo Alegria,M. John Chapman,Paul N. Durrington,Serap Erdine,Julian Halcox,Richard J. Hobbs,John Kjekshus,Pasquale Perrone Filardi,Gabriele Riccardi,Robert F. Storey,David R. Wood +17 more
Journal ArticleDOI
Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study
W M Verschuren,David R. Jacobs,Bennie P. M. Bloemberg,Daan Kromhout,Alessandro Menotti,Christ Aravanis,Henry Blackburn,Ratko Buzina,Anastasios Dontas,Flaminio Fidanza +9 more
TL;DR: The large difference in absolute CHD mortality rates at a given cholesterol level, however, indicates that other factors, such as diet, that are typical for cultures with a low CHD risk are also important with respect to primary prevention.
Related Papers (5)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)☆☆☆
Alberico L. Catapano,Zeljko Reiner,Guy De Backer,Ian D. Graham,Marja-Riitta Taskinen,Olov Wiklund,Stefan Agewall,Eduardo Alegria,M. John Chapman,Paul N. Durrington,Serap Erdine,Julian Halcox,Richard J. Hobbs,John Kjekshus,Pasquale Perrone Filardi,Gabriele Riccardi,Robert F. Storey,David R. Wood +17 more